Activities - how the charity spends its money
Support for those affected by Myelodysplastic Syndrome, ("MDS"), which is a rare blood cancer.
We provide: national & regional meetings with specialist speakers, a website & newsletter, campaigning for access to treatment, a networking service for MDS patients to share experiences & support; cooperate with all UK MDS clinical experts; support clinical trials and research into MDS.
Income and expenditure
Data for financial year ending
31 March 2021
Total income: £180,512
Total expenditure: £155,999
Employees with total benefits over £60,000
No employees have total benefits over £60k for this charity
This charity raises funds from the public but does not work with professional fundraisers or commercial participators.
This charity does not have any trading subsidiaries.
No trustees receive any remuneration, payments or benefits from the charity.